2- (4-0x0-4H-quinaz0lin-3-yl) acetamides and their use as vasopressin V3 antagonists

Details for Australian Patent Application No. 2006221962 (hide)

Owner N.V. Organon Pharmacopeia Drug Discovery, Inc.

Inventors Letourneau, Jeffrey; Jokiel, Patrick; Napier, Susan Elizabeth; Chan, JuiHsiang; Ohlmeyer, Michael; Ho, KocKan; Neagu, Irina; Riviello, Christopher; Morphy, John Richard

Agent Spruson & Ferguson

Pub. Number AU-A-2006221962

PCT Pub. Number WO2006/095014

Priority 60/660,926 11.03.05 US; 60/715,875 09.09.05 US

Filing date 10 March 2006

Wipo publication date 14 September 2006

International Classifications

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/095014 Priority application(s): WO2006/095014

29 November 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read 2- (4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006221964-Anti-proliferative combination therapy comprising satraplatin or JM118 and a taxane

2006221957-Amido-substituted 6-phenylphenanthridines